/Investor DB

Angelini Ventures — Full Portfolio

36 tracked investments · listed companies and verified rows first

Argobiostudioargobiostudio.comin𝕏✓ verified

Argobio is an operational venture builder in biotechnology sponsored by five strategic investors including venture capital and pharmaceutical partners.

AI & Machine LearningBiotechDeep TechHealthtech

Yves Ribeill(Partner & EIR)inNeill Moray Mackenzie(Partner & EIR)inPoul Sørensen(Partner & EIR)in

BoardRémi Soula(Partner & EIR)

Co-investorsKurma PartnersBpifrance

Genialisgenialis.comin✓ verified

Genialis is a precision oncology company that applies data analysis to help drug developers understand mechanisms of action, resistance, and patient stratification for cancer therapies.

AI & Machine LearningBiotechDigital HealthMedical DevicesBoston, US

Miha Štajdohar(Executive Officer, Director)inRafael Rosengarten(Chief Executive Officer and Co-founder)inLuka Ausec(Executive Officer)inHamzeh Abdul-Hadi(Director)Tjasa Krisper Kutin(Executive Officer)

BoardIta Lu(Director)in

Co-investorsTaiwania CapitalDebiopharm Innovation FundFirst Star VenturesScaleX Venturesredalpine

Nouscomnouscom.com✓ verified

Nouscom is a biotech company whose investors page lists its venture capital backers.

BiotechHealthtech

Riccardo Cortese(Co-Founder)Marina Udier(Chief Executive Officer and Board Director)Elisa Scarselli(Chief Scientific Officer and Co-Founder)Alfredo Nicosia(Co-founder)Antonella Folgori(Co-founder)Stefano Colloca(Co-founder)

Co-investors5AM VenturesAndera PartnersRevelation PartnersXGEN VentureBpifranceEQT Life Sciences+6 more

Nuevocornuevocor.comin✓ verified

Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases.

BiotechDigital HealthHealthtechMedical DevicesSingapore, SG

Brian Burke(Co-Founder and Advisor)inMark Kay(Co-Founder and Advisor)Colin Stewart(Co-Founder and Advisor)Yann Chong Tan(Co-Founder and Advisor)inMonica Shah(Chief Medical Officer)inAl Gianchetti(Chief Executive Officer)in

Co-investorsKurma PartnersBoehringer Ingelheim Venture FundClavystBioHighlight CapitalSEEDS Capital

Adcytherixadcytherix.com

Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) that use approved cancer drugs as payloads combined with optimized conjugation design to overcome resistance in precision oncology.

BiotechHealthtechMedical Devices

Jack Elands(Founder & CEO)inXavier Preville(Co-founder, VP & Head of Research & Preclinical Development)inJan H.M. Schellens(Chief Medical Officer)inThierry Menguy(VP & Head of CMC Operations)inJaime Arango(Chief Financial Officer)inPaul Jackson(Chief Operating Officer)in

Co-investorsaMoonRA CapitalBpifranceAndera PartnersKurma PartnersPontifax Venture Capital+1 more

AgelessRxagelessrx.comin𝕏Aug 2026

AgelessRx offers prescription weight management medications delivered through a telehealth platform, including GLP-1 medications (semaglutide, tirzepatide), FDA-approved weight loss drugs (Wegovy, Zepbound), and supportive treatments like metformin and vitamin injections for adults seeking medically-supervised weight loss.

BiotechDigital HealthDirect to ConsumerHealthtechLongevityAnn Arbor, US

Anar Isman(Co-Founder & Chief Executive Officer)inRobert Michael Pejovich(Director of Finance of the Issuer)

Co-investors1/1 Capitalabrdn plcFidelity InvestmentsJanus Henderson InvestorsSanofi Ventures

Avation Medicalavation.comin𝕏Feb 2024 · $22M

Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.

Digital HealthHealthtechMedical DevicesValencia, US

Manish Vaishya, PhD(Chief Executive Officer, Co-Founder & Board Member)Jill Schiaparelli(Executive Officer, Director)inKevin Wasserstein(Director)

BoardThomas Shehab, MD(Director)

Co-investorsArboretum VenturesAsahi Kasei Corporate Venture CapitalAvestria VenturesShangBay Capital LLC

Cadence Neurosciencecadenceneuro.cominMay 2023 · $26M

Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy.

BiotechDigital HealthHealthtechMedical DevicesSammamish, US

Kent Leyde(Executive Officer, Director, Promoter)inWarren Douglas Sheffield(Executive Officer, Director, Promoter)

Co-investorsJAZZ Venture PartnersLumira VenturesF-Prime CapitalIaso VenturesMayo Clinic Ventures

Comindcomind.ioin𝕏

CoMind develops neuromonitoring devices and neural interfaces aimed at measuring and treating the brain to improve patient outcomes across the care continuum.

Deep TechHardwareHealthtechMedical Devices

James Dacombe(Founder and Chief Executive Officer)inSimon Morling(Chief Technology Officer)inRob Cooper(Chief Scientific Officer)inChema Garcia-Soto(Chief Commercial Officer)inMarc Bloom(Chief Medical Officer)in

Co-investorsBackedCrane Venture PartnersLocalGlobeOctopus VenturesPhoenix Court

Congruence Therapeuticscongruencetx.comin

Congruence is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to model proteins in their full dynamic state and predict disease correction in silico.

AI & Machine LearningBiotechDeep Tech

Clarissa Desjardins(Founder)in

Co-investorsOrbiMedAlexandriaDIMENSIONBDC Thrive Venture Fund for WomenLumira VenturesAmplitude Venture Capital+1 more

Cour Pharmacourpharma.comin𝕏

COUR develops antigen-specific immunotherapies that reprogram the immune system to treat the underlying causes of autoimmune and immune-mediated diseases while preserving normal immune function.

BiotechHealthtech

Co-investorsAlpha Wave GlobalLumira VenturesRoche Venture FundJDRF T1D Fund

DAMONA Pharmaceuticalsdamonapharma.comin

Damona develops precision neuromedicines aimed at treating cognitive deficits associated with neurodegenerative and psychiatric disorders such as Alzheimer's disease, depression, and schizophrenia.

BiotechDeep TechDigital HealthHealthtechMedical Devices

Co-investorsLumira VenturesNoeticToronto Innovation Acceleration Partners

Elkedoniaelkedonia.comin

Elkedonia is a biotech company developing a novel antidepressant treatment that targets intracellular neuroplasticity pathways rather than synaptic mechanisms, with the goal of providing rapid, long-lasting relief for depression patients.

BiotechDigital HealthMental Health

Delphine Charvin(Founding Chief Executive Officer & Board Director)inMélanie Rouillier(VP, Chief Operations Officer & Co-Founder)inJocelyne Caboche(President of the Scientific Advisory Board & Co-Founder)in

Co-investorsCARMA FUNDKurma PartnersSambrinvest

Epicrispr Biotechnologiesepicrispr.comin𝕏May 2018

Epic CRISPR develops GEMS (Gene Expression Modulation System), a modular epigenetic editing platform that combines DNA-binding proteins, guide RNAs, and modulator proteins to create genetic medicines.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US

Lei Stanley Qi(Scientific Founder)inAmber Salzman(Executive Officer, Director)inHaorui Zhang(Executive Officer, Director)

BoardAndrew Lam(Director)Anran Li(Director)Jennifer King(Director)

Co-investorsAlly Bridge Groupabrdn plcFidelity InvestmentsJanus Henderson InvestorsSanofi Ventures

Freya Biosciencesfreyabiosciences.comin

Freya Biosciences develops innovative therapies targeting immune-mediated diseases that affect women.

BiotechFemTechHealthtech

Colleen Acosta, PhD(CEO, Co-Founder)Johan van Hylckama Vlieg, PhD(CSO, Co-Founder)

Co-investorsIndaco Venture PartnersOMX VenturesSofinnova PartnersBill & Melinda Gates Foundation

Handspring Healthhandspringhealth.comin

Handspring provides virtual mental health therapy for children, teens, and young adults, with insurance coverage and rapid access to care without waitlists.

Digital HealthHealthtechMental Health

Sahil Choudhryin

Co-investors25MadisonCobalt VenturesCornucopian Capital ManagementNextView VenturesNVP CapitalRPS Ventures+4 more

Hyperspectralhyperspectral.aiinApr 2026

HyperSpectral develops a spectral sensing and AI layer for Physical AI that interprets matter through spectral data, molecular identification, and AI architecture.

AI & Machine LearningDeep TechDefense TechHardwareAlexandria, US

Matthew Theurer(Executive Officer, Director)Lauren Stack(Executive Officer, Director)inVincent Lubsey(Executive Officer)

BoardJuan Lopez(Director)inWilliam Porteous(Director)in

Co-investorsKibo VenturesRRE VenturesGlade Brook Capital PartnersHeal CapitalLifeX VenturesThe Engine Ventures+1 more

Hypervision Surgicalhypervisionsurgical.comin𝕏Apr 2026

Hypervision Surgical develops an intraoperative hyperspectral imaging system that uses AI to provide real-time, contrast-free tissue characterisation during surgery.

AI & Machine LearningHealthtechMedical Devices

Co-investorsHeal CapitalHeran PartnersLifeX VenturesMeridian Health VenturesSonorcapZEISS Ventures+2 more

Laigo Biolaigobio.comin

Laigo Bio develops targeted protein degradation therapies using its SureTACs (Surface Removal Targeting Chimeras) platform, which uses bispecific antibodies to direct cell-surface proteins toward lysosomal degradation via membrane-bound E3 ligases.

BiotechHealthtech

Co-investorsCurie CapitalKurma Partners

nobinobi.lifeJan 2025 · $37M

Nobi manufactures intelligent lamps equipped with optical sensors and artificial intelligence to detect falls and monitor health for elderly care in residential facilities and home settings.

AI & Machine LearningHealthtechIoT

Roeland Pelgrims(Founder)inBert De Haes(Founder)Stijn Verrept(Founder)

Co-investors15th RockEQT Life SciencesPMVSkystar Capital

Noctrix Healthnoctrixhealth.comJan 2024 · $40M

Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.

Digital HealthMedical DevicesWellness & FitnessPleasanton, US

Shri Raghunathan(Founder)inShriram Raghunathan(Executive Officer, Director)

BoardChau Khuong(Director)inAllan May(Director)Mudit Jain(Director)inTracy Pappas(Director)in

Co-investorsBlue Venture FundsJoyance PartnersOrbiMedTreo Ventures, LlcZühlke VenturesBridge Bank+2 more

Nuclidiumnuclidium.comin

Nuclidium develops copper-based radioligand therapeutics and diagnostics for cancer treatment and diagnosis, with programs targeting prostate and breast cancer using Copper-61 and Copper-67 isotopes.

BiotechDeep TechHealthtechMedical DevicesBasel, CH

Leila Jaafar(CEO)Gustav(Medical Advisor)

Co-investorsDeepTech & Climate FondsKurma PartnersNeva Sgr.VIVES Partners

Pretzel Therapeuticspretzeltx.cominSep 2022

Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression.

BiotechDeep TechHealthtechMedical Devices

Michal Minczuk(Co-Founder)inGabriel Martinez(Chief Scientific Officer & Co-Founder)Claes Gustafsson(Co-Founder)Maria Falkenberg(Co-Founder)Nils-Göran Larsson(Co-Founder)Gabriel Martinez, Ph.D.(Chief Scientific Officer & Co-Founder)

Co-investorsARCH Venture PartnersCambridge Innovation CapitalEIR VenturesGV (Google Ventures)HealthCapInvus+2 more

Serenisserenis.itinSep 2025

Serenis is an online mental health platform offering video sessions with vetted psychologists, psychotherapists, psychiatrists, coaches, and nutritionists, covering individual, couples, ADHD, psychiatry, sexology, and eating-disorder care.

Digital HealthMarketplacesMental Health

Daniele Francescon(Founder)inSilvia Wang(Founder)

Co-investorsGruppo BertoldiLumen VenturesCDP Venture CapitalInvictus Capital

Therini Biotherinibio.cominMay 2025 · $39M

Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.

BiotechDigital HealthHealthtechMedical DevicesSacramento, US

Katerina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKaterina Akassoglou, PhD(Scientific Founder)Leslie Schulze(Executive Officer)Tara Nickerson(Executive Officer, Director)in

BoardOlga Danilchanka(Director)inLaia Crespo-Martin(Director)

Co-investorsMRL Ventures FundSanofi VenturesSV Health InvestorsDementia Discovery FundDolby Family VenturesMitsui Global Investment+2 more

Vantisvantis-health.comMar 2025

Vantis develops AI-based assistance systems and technology for primary care, aimed at supporting physicians in everyday clinical work by simplifying processes and making medical information more usable.

AI & Machine LearningDigital HealthHealthtechMunich, DE

Maximilian Roedel(Founder)

Co-investorsBayBG Venture CapitalBayern Kapitalb2venturefirstminute capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Arclight TherapeuticsArgobioCongruenceCourExtendGenEpHandspringHypervision SurgycalNEUmiRNANoctrix

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.